Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with 18F-FDG PET/CT:A Single-Center Prospective Study

Autor: Louise M. Risør, Malene M. Clausen, Zaza Ujmajuridze, Mohammed Farhadi, Kim F. Andersen, Annika Loft, Jeppe Friborg, Andreas Kjaer

Publikováno v: Risør, L M, Clausen, M M, Ujmajuridze, Z, Farhadi, M, Andersen, K F, Loft, A, Friborg, J & Kjaer, A 2022, ' Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with 18 F-FDG PET/CT : A Single-Center Prospective Study ', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 63, no. 8, pp. 1169-1176 . https://doi.org/10.2967/jnumed.121.262866

Purpose: The aim of this phase II trial (NCT02965001) was to evaluate the prognostic value of urokinase-type plasminogen activator receptor (uPAR)-PET/CT with the novel ligand 68Ga-NOTA-AE105 in head and neck cancer and compare it to 18F-fluorodeoxyg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95b9ac39d5208a68c1c3a163015dca10
https://curis.ku.dk/ws/files/358554398/Prognostic_Value_of_Urokinase.pdf